A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 216 participants.
Also called NCT07109700
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 216 participants
- Registry
-
NCT07109700
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07109700. Randomized; double masking; primary purpose treatment. Start 2025-04-30 (actual); primary completion 2026-01-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- HDM1005 1
- Intervention (Drug)
- HDM1005 2
- Intervention (Drug)
- HDM1005 3
- Intervention (Drug)
- HDM1005 4
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Dulaglutide 1.5 MG
- Lead sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct07109700- Content hash
6510dea03a5e6f13bfd001262b66bffe88ca11ad6d5166189383628f06753efe